Retina Today

What Retina Today does

Retina Today is a privately held medical trade publication focused on the ophthalmology sub-specialty of retina, founded in 2006 and operated by Bryn Mawr Communications, LLC from Wayne, Pennsylvania. The publication delivers peer-reviewed clinical content, surgical technique guidance, and coverage of therapeutic developments in medical retina, retinal surgery, vitreous disease, diabetic retinopathy, retinal imaging, pediatric retina, posterior segment oncology, and ocular trauma to practicing vitreoretinal surgeons, medical retina specialists, uveitis experts, and retina fellows in training. Content is produced under Chief Medical Editors Allen C. Ho, MD and Robert L. Avery, MD, supported by an Editorial Advisory Board of prominent retina specialists and contributing authors from leading academic and clinical institutions.

The company's product portfolio is structured as an integrated media ecosystem rather than a single publication. The core Retina Today print and digital magazine is complemented by Eyetube (a video and podcast platform featuring New Retina Radio, Retinaws, Formula Retina 3D, and Clinical Minute Retina series), Eyewire+ (a retina industry news service), and YoungMD Connect (a networking and educational platform for retina trainees). The technology foundation is a content management system–driven website (retinatoday.com) with image delivery via CDN, alongside email newsletter distribution, social media presence across Facebook, Instagram, LinkedIn, and X/Twitter, and a robust print subscription logistics chain operated via ezsub.com. Additional offerings include a searchable article archive, a conference calendar covering AAO, ARVO, ASRS, ARDS, and Euretina, and sponsored editorial supplements on therapeutic pipeline topics.

Retina Today operates a freemium, two-sided media business model. Retinal specialists receive free print and email subscriptions, with global distribution channels for both print and digital content; the audience does not pay directly for content consumption. Revenue is generated primarily through advertising and sponsored educational supplements from pharmaceutical and medical device companies, with named advertiser relationships spanning Genentech, Astellas, Abbvie, Regenxbio, Allergan, and Zeiss. The company's broader footprint is defined by its parent, Bryn Mawr Communications, LLC, which also publishes Cataract & Refractive Surgery Today, Glaucoma Today, and Modern Optometry — establishing Retina Today as part of a multi-title ophthalmology media portfolio rather than a standalone enterprise. The company is independently owned with no recorded external investment, M&A activity, or public ownership.

Name

Retina Today

Legal name

Bryn Mawr Communications, LLC

Website

https://retinatoday.com

Company type

Private

Founded year

2006

Operating status

Operating

Headcount range

51–100 employees

Short description

Retina Today is a privately held medical trade publication delivering peer-reviewed clinical content on retinal disease, surgery, and ophthalmic therapeutics to vitreoretinal specialists and fellows, monetized primarily through pharmaceutical and medical device advertising plus sponsored educational supplements.

Ownership category

akta.pro rank

Product category

Ophthalmology Medical Publishing

NAICS

Newspaper, Periodical, Book, and Directory Publishers (5131)

SIC

Periodicals: Publishing Or Publishing & Printing (2721)

akta.pro primary industry

Retina & Vitreous Specialists (HLAKAKAE)

akta.pro secondary industry

Ophthalmology Specialty Pharmaceuticals (HLAIACAK)

Keywords

• Medical publishing
• Ophthalmology content
• Retina research
• Clinical journalism
• Continuing medical education

Headquarters

HQ city

Wayne

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Digital Commerce or Content

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D

Pricing tiers

Distribution channels6 records

Marketing channels7 records

Core offering

Retina Today is a medical trade publication that delivers peer-reviewed clinical content on medical retina, retinal surgery, vitreous, diabetes, retinal imaging, pediatric retina, posterior segment oncology, and ocular trauma to practicing retina specialists. Content is distributed free of charge across print, website, email newsletter, podcast (New Retina Radio), and video (Eyetube) channels, with revenue generated through pharmaceutical-sponsored supplements and advertising from companies such as Genentech, Astellas, Abbvie, Regenxbio, Allergan, and Zeiss.

Product overview

Retina Today is a medical publication providing print and digital content covering research and clinical developments in medical retina, retinal surgery, vitreous, diabetes, retinal imaging, pediatric retina, posterior segment oncology, and ocular trauma. The portfolio includes the core Retina Today publication, the Eyetube video/podcast platform, the Eyewire+ news platform, and the YoungMD Connect community platform. Additional offerings include sponsored supplements on therapeutic topics, a conference calendar, and an article archive. Content is distributed through subscriptions, website access, and podcast/video streaming.

Differentiator

Problem solved

Functional benefit

Products and services

• Retina Today Publication Medical trade publication (print and digital) delivering peer-reviewed clinical content on medical retina, retinal surgery, vitreous, diabetes, retinal imaging, pediatric retina, posterior segment oncology, and ocular trauma, targeted at practicing vitreoretinal surgeons, medical retina specialists, and uveitis experts.
• Eyetube Video and podcast platform featuring retina-focused educational content including the New Retina Radio Journal Club, Retinaws, Formula Retina 3D, and Clinical Minute Retina series, with meeting coverage from AAO, ARVO, ASRS, and other major retina conferences.
• Eyewire+
• YoungMD Connect
• Retina Today Sponsored Supplements

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Recent moves5 records

Expansion highlights5 records

Direct peers

• Healio Ophthalmology: Digital specialty medical news and education platform serving ophthalmologists, including retina specialists. Comparable as a multi-format B2B medical media property with advertising, CME, and sponsored content offerings.
• Modern Optometry: Another Bryn Mawr Communications specialty publication, focused on optometrists. Comparable as a sibling B2B trade publication with the same freemium and advertising-supported model targeting eye-care professionals.
• Ophthalmology Times: Long-established trade publication covering ophthalmology, including retina topics. Directly comparable as a multi-platform B2B medical media property serving ophthalmologists and retina specialists with advertising and sponsored content.
• Ocular Surgery News: Trade news publication focused on ophthalmic surgery, including retina. Comparable as a digital-first B2B medical media outlet selling advertising and sponsored content to ophthalmologists and retina specialists.
• Review of Ophthalmology: Print and digital trade publication for ophthalmologists covering clinical and surgical retina. Directly comparable as a long-running niche B2B publication monetized through advertising and sponsored educational content.
• Retina Specialist: Trade publication dedicated to retina specialists. Directly comparable as a niche B2B publication targeting the same vitreoretinal specialist audience with advertising- and supplement-driven revenue.
• Glaucoma Today: Another Bryn Mawr Communications specialty publication serving ophthalmologists. Comparable as a sibling B2B trade publication with an identical advertising- and supplement-driven model, though focused on glaucoma rather than retina.
• Cataract & Refractive Surgery Today: Sister publication under Bryn Mawr Communications, LLC, covering cataract and refractive surgery. Directly comparable as a same-publisher B2B medical media brand with the same advertising/sponsored supplement model targeting ophthalmologists.

Broad incumbents

• American Society of Retina Specialists (ASRS): Professional society serving retina specialists with publications, meeting coverage, and educational content. Comparable as a content and meeting-coverage hub for the same audience, though not a commercial publisher.
• American Academy of Ophthalmology (AAO) Publications: AAO's EyeNet Magazine and broader publishing portfolio serve the entire ophthalmology profession, including retina specialists. Comparable as a major incumbent ophthalmology publisher with overlapping audience and advertiser relationships, but with society backing and broader scope.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/retinaToday
• Facebookfacebook.com/RetinaToday
• LinkedInlinkedin.com/company/retina-today
• Instagraminstagram.com/retina_today

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Retina Today